*** Notice: For the protection of property rights, this catalog is available for online browsing only. Please drop us a line if you would like to receive a copiable version of this catalog. Thank You!
Mark Watanabe, PharmD; Barbara Poddig, PharmD, BCPP; LaGenia Bailey, PharmD; Mark E. Schneiderhan, PharmD, BCPP
Describe the therapeutic goals of using typical antipsychotic agents; Understand the common side effects of typical antipsychotic agents; Identify characteristics of "High potency" vs "Low potency" antipsychotic agents.
Laura Miller, MD; Katherine L. Wisner, MD; Susan Baab, RN, MSN, CS
Understand the clinical features of ostpartum 'blues', depression and psychoses. Understand the differences in clinical presentation and correlates, etiology and course of illness for the three categories of postpartum disorders; Identify medications which are reasonable choices for women with postpartum depression; Develop a monitoring plan for babies whose mothers take antidepressants and breastfeed; Learn the precautions of treating them under those circumstances; Gain an understanding of the best treatment options for postpartum bipolar women, including breastfeeding mothers, after a careful cost-risk analysis.
Robert L. Spitzer, MD; K. Ranga Krishnan, MD; Sheldon H. Preskorn, MD
This program features leading medical experts presenting information on short and long term treatment of mood disorders. The faculty will address diagnosis, treatment options, clinical drug therapy, and management of mood disorders in the older patient. Additional topics wil be: polypharmacy, comorbid medical conditions, drug interactions, and the impact of depression on cognition, functions, and motor skills.
Recognize and formally diagnose social phobia using DSM-IV; Differentiate social phobia from other primary and secondary anxiety disorders; Identify the disorders which tend to be commonly comorbid with social phobia; understand indications for drug therapy, cognitive behavior therapy, and combined treatment for social phobia; Describe classes of drugs most appropriate in treatment and first line treatments and follow-up treatment in case of non-response.
Mark D. Watanabe, PharmD, PhD; S. Charles Schulz, MD; Peter F. Buckley, MD
Define the demographic characteristics of schizophrenia; Appreciate the core diagnostic features of schizophrenia; Discuss which conditions mimic the presentation of schizophrenia; Understand the role of ancillary tests and other information in differentiating schizophrenia from neurological conditions; Identify new drugs available for full syndrome of schizophrenia; Distinguish the difference between the effects of traditional drugs and new drugs; Describe the current theories proposed for the pathogenesis of schizophrenia and their implications for rational drug therapy.
Gail Stuart, PhD, RN, CS, FAAN; Michele Laria, MSN, RN; Linda Beeber, PhD, RN; Carol Glod, MS, RN
Prominent physicians and nurses discuss the fundamentals of depression and its detection as well as treatment options for the disease. Specific topics include: definition, epidemiology, consequences and diagnosis of depression/patient education and compliance counseling; etiology of depression; treatment options - psychotherapy; treatment options - medications.
Steven F. Pariser, MD; Kimberly A. Yonkers, MD; Susan Kornstein, MD; Anthony Rothschild, MD; Lee Cohen, MD; Zachary N. Stowe, MD
Premenstrual Dysphoric Disorder; Treatment Options for the Female Patient; Menopause, Peri-Menopause, and Depression; Depression in Pregnancy and the Postpartum State.
Phebe Tucker, MD; Lawrence J. Cohen, PharmD, FASHP; Charles B. Nemeroff, MD, PhD; Charles F. Reynolds III, MD; Kevin Scott Ferentz, MD
Explains short and long term treatment in the elderly, describes clinical drug therapy or treatment protocols, reviews disease management of depression in the managed care setting, discusses pharmacoeconomics of depression and explains the contemporary management of depression.
S. Atezar Saeed, MD; Williams S. Gilmer, MD; Timothy J. Bruce, PhD; Sandra Hable, RN, EdM., LCPC
Recognize and diagnose bipolar disorder using DSM-IV criteria; Address important diagnostic considerations in classifying bipolar disorder; Identify the disorders which tend to be commonly comorbid bipolar disorder; Describe the classes of drugs most appropriate for treatment and factors in choosing an appropriate first line treatment and follow-up treatments in case of non-response.
James H. Kocsis, MD; Sanford Finkel, MD; Paul J. Goodnick, MD; Andrew Winokur, MD, PhD; Susan G. Kornstein, MD
Review developments in the diagnosis of patients with depressive disorders; Review approaches to treatment; Review current status of preventing relapse; Review and focus on the needs of special populations with depression.
Sy Atezaz Saeed, MD; Donald W. Black, MD; Sandra Hable, RN, EdM; Timothy Bruce, PhD
Recognize and formally diagnose social phobia using DSM-IV; Differentiate social phobia from other primary and secondary anxiety disorders; Identify the behavior therapy and combined treatment for obsessive-compulsive disorder; Describe the classes of drugs most appropriate in the treatment of this disorder and factors in determining the appropriate first line treatment and followup in case of non-response.
Mary E. Muscari, PhD, CRNP, CS; Marrian Farrell, PhD, RNC, CS
Be able to describe clinical manifestations and potential complications associated with anorexia and bulimia nervosa; discuss nursing techniques used to prevent and manage the physiologic consequences; develop an understanding of the psychosocial needs of clients with eating disorders; and select psychosocial interventions based on appropriate theoretical perspectives for clients with eating disorders.
David Katerndahl, MD; Laszlo Papp, MD; Eric Hollander, MD; Dennis Charney, MD and Panelist, Martha J. Haun, MD
Care-Seeking Behavior in Panic Disorder & Physician Recognition, Panic Disorders, Obsessive-Compulsive and Related Disorders, Post-Traumatic Stress Disorder and Generalized Disorders.
Norman Guzick, MD; Phoebe Rich, MD - John Wolf, MD; H. Irving Katz, MD
Psychosocial Ramifications and Epidemiology; Diagnosis and Differential; Current Treatment Strategies for Onychomycosis; Safety Concerns Regarding Drug Interaction Potential and Liver Metabolism